Jeff Baxter

Mr. Jeffrey R. Baxter is a President, Chief Executive Officer & Director at VBI Vaccines, Inc., an Independent Non-Executive Director at Chromadex Corp., a President, Chief Executive Officer & Director at VBI Vaccines (Delaware), Inc. and a President, Chief Executive Officer & Director at Variation Biotechnologies (US), Inc. He is on the Board of Directors at VBI Vaccines, Inc., Chromadex Corp., VBI Vaccines (Delaware), Inc. and Variation Biotechnologies (US), Inc. Mr. Baxter was previously employed as a SVP-Finance, Operations, Research & Development by GlaxoSmithKline Plc, a Principal by British American Tobacco plc, a Managing Partner by The Column Group LLC, and a Principal by Unilever Plc. He received his undergraduate degree from Thames Valley University.